High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis. [electronic resource]
Producer: 20021119Description: 1079-83 p. digitalISSN:- 0315-162X
- Adolescent
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Arthritis, Juvenile -- drug therapy
- Child
- Child, Preschool
- Cyclooxygenase 1
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors -- administration & dosage
- Drug Therapy, Combination
- Female
- Humans
- Isoenzymes -- antagonists & inhibitors
- Male
- Meloxicam
- Membrane Proteins
- Patient Satisfaction
- Prostaglandin-Endoperoxide Synthases
- Thiazines -- administration & dosage
- Thiazoles -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.